Related references
Note: Only part of the references are listed.Single-Cell Transcriptome Atlas of Murine Endothelial Cells
Joanna Kalucka et al.
CELL (2020)
Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies
Leander Huyghe et al.
EMBO MOLECULAR MEDICINE (2020)
The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer
John Kwon et al.
CANCER DISCOVERY (2020)
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
DNA Damage and Cancer Immunotherapy: A STING in the Tale
Timo Reislander et al.
MOLECULAR CELL (2020)
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic
Emily N. Chin et al.
SCIENCE (2020)
Trial watch: STING agonists in cancer therapy
Julie Le Naour et al.
ONCOIMMUNOLOGY (2020)
A MST1-FOXO1 cascade establishes endothelial tip cell polarity and facilitates sprouting angiogenesis
Yoo Hyung Kim et al.
NATURE COMMUNICATIONS (2019)
HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity
Shiying Wu et al.
NATURE CELL BIOLOGY (2019)
STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
Hannah Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy
Liping Huang et al.
NATURE COMMUNICATIONS (2019)
Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity
Linda Schadt et al.
CELL REPORTS (2019)
Cytosolic DNA Sensing in Organismal Tumor Control
Claire Vanpouille-Box et al.
CANCER CELL (2018)
An overview on Vadimezan (DMXAA): The vascular disrupting agent
Amir Daei Farshchi Adli et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
Chromosomal instability drives metastasis through a cytosolic DNA response
Samuel F. Bakhoum et al.
NATURE (2018)
TNF alpha and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors
Brian J. Francica et al.
CANCER IMMUNOLOGY RESEARCH (2018)
iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data
Steven Xijin Ge et al.
BMC BIOINFORMATICS (2018)
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
Assaf Marcus et al.
IMMUNITY (2018)
Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
Kelsey E. Sivick et al.
CELL REPORTS (2018)
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Lionel B. Ivashkiv
NATURE REVIEWS IMMUNOLOGY (2018)
Genetically engineered mouse models in oncology research and cancer medicine
Kelly Kersten et al.
EMBO MOLECULAR MEDICINE (2017)
YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation
Jongshin Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Transcriptional regulation of endothelial cell behavior during sprouting angiogenesis
Hyun-Woo Jeong et al.
NATURE COMMUNICATIONS (2017)
Modulation of telomere protection by the PI3K/AKT pathway
Marinela Mendez-Pertuz et al.
NATURE COMMUNICATIONS (2017)
Signalling strength determines proapoptotic functions of STING
Muhammet F. Gulen et al.
NATURE COMMUNICATIONS (2017)
Decreased expression of STING predicts poor prognosis in patients with gastric cancer
Shushu Song et al.
SCIENTIFIC REPORTS (2017)
The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression
Julia M. Weiss et al.
ONCOIMMUNOLOGY (2017)
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy
Christopher A. Klebanoff et al.
JCI INSIGHT (2017)
Preclinical mouse solid tumour models: status quo, challenges and perspectives
Nicolas Gengenbacher et al.
NATURE REVIEWS CANCER (2017)
The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3
Moritz M. Gaidt et al.
CELL (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer
Qing Chen et al.
NATURE (2016)
Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing
Qi Chen et al.
NATURE IMMUNOLOGY (2016)
Mechanisms and regulation of endothelial VEGF receptor signalling
Michael Simons et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Treatment modifications in tumour necrosis factor-α (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas
Jan P. Deroose et al.
EUROPEAN JOURNAL OF CANCER (2015)
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
Olivier Demaria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Tumor angiogenesis, from foe to friend
Lee B. Rivera et al.
SCIENCE (2015)
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Juan Fu et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
Akt Inhibition Enhances Expansion of Potent Tumor-Specific Lymphocytes with Memory Cell Characteristics
Joseph G. Crompton et al.
CANCER RESEARCH (2015)
STING: infection, inflammation and cancer
Glen N. Barber
NATURE REVIEWS IMMUNOLOGY (2015)
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini et al.
ANNALS OF MEDICINE (2014)
Neurons Limit Angiogenesis by Titrating VEGF in Retina
Keisuke Okabe et al.
CELL (2014)
FoxO1-Mediated Activation of Akt Plays a Critical Role in Vascular Homeostasis
Harita Dharaneeswaran et al.
CIRCULATION RESEARCH (2014)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
DMXAA Causes Tumor Site-Specific Vascular Disruption in Murine Non-Small Cell Lung Cancer, and like the Endogenous Non-Canonical Cyclic Dinucleotide STING Agonist, 2′3′-cGAMP, Induces M2 Macrophage Repolarization
Charlene M. Downey et al.
PLOS ONE (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
Joseph Conlon et al.
JOURNAL OF IMMUNOLOGY (2013)
Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP
Andrea Ablasser et al.
NATURE (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
BrafV600E cooperates with Pten loss to induce metastatic melanoma
David Dankort et al.
NATURE GENETICS (2009)
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system
Hellmut G. Augustin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Distinctive role of integrin-mediated adhesion in TNF-induced PKB/Akt and NF-κB activation and endothelial cell survival
G. Bieler et al.
ONCOGENE (2007)
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis
Zachary J. Roberts et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
Teru Hideshima et al.
BLOOD (2006)
Targeting the PI3K-Akt pathway in human cancer: Rationale and promise
J Luo et al.
CANCER CELL (2003)
Share Paper
